2016年至2021年马萨诸塞州波士顿接受门诊胃肠外抗生素治疗的患者丙型肝炎治疗结果评估
Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy-Boston, Massachusetts, 2016-2021.
作者信息
Gupta Akash, Ashour Dina, Shebl Fatma M, Platt Laura, Chiosi John J, Nelson Sandra B, Ard Kevin L, Kim Arthur Y, Bassett Ingrid V
机构信息
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
出版信息
Open Forum Infect Dis. 2023 Jul 5;10(7):ofad342. doi: 10.1093/ofid/ofad342. eCollection 2023 Jul.
In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should consider concurrent HCV treatment during OPAT.
在我们2016年至2021年位于波士顿的门诊肠外抗生素治疗（OPAT）项目中，我们发现，丙型肝炎病毒（HCV）感染活跃的患者中，由其OPAT治疗医生开具HCV治疗处方的比例较低，且很少有人实现病毒学持续应答。临床医生应考虑在OPAT期间同时进行HCV治疗。
Zotero 插件